4//SEC Filing
Lutz Robert Matthew 4
Accession 0001179110-20-000875
CIK 0001634432other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 6:25 PM ET
Size
5.3 KB
Accession
0001179110-20-000875
Insider Transaction Report
Form 4
Lutz Robert Matthew
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2020-01-27+275,000→ 275,000 totalExercise: $2.98Exp: 2030-01-27→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]This option vests in sixteen equal quarterly installments beginning April 27, 2020, provided the Reporting Person is employed by the Issuer on each vesting date.
Documents
Issuer
Strongbridge Biopharma plc
CIK 0001634432
Entity typeother
Related Parties
1- filerCIK 0001786203
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 6:25 PM ET
- Size
- 5.3 KB